Estela Rodriguez

Join Dr. Estela Rodriguez, a thoracic oncologist at Sylvester Comprehensive Cancer Center, as she unpacks the nuances of managing ROS1 fusion positive non-small cell lung cancer. Discover the vital role of comprehensive NGS in treatment planning, and delve into the insights on various tyrosine kinase inhibitors like crizotinib and repotrectinib. Estela highlights common side effects, effective management strategies for toxicities, and the critical importance of patient education and regular follow-ups in optimizing care.